Skip to main content
TECHi home
Methodology published · Market data, model notes, and corrections process are public · Data policy · Corrections policy
ABT logo

NYSE · Technology · Holders

Abbott Laboratories (ABT) Institutional Ownership & Insider Trading History

Recent insider purchases and sales for ABT from Form 4 filings. Institutional holdings surface here when ownership sources publish.

Section freshness

Price Jun 26, 4:03 PM EDT · Statements Mar 30, 8:00 PM EDT

Source timingDetails

Data freshness

Prices update fastest. Fundamentals, analyst data, and news update on their own schedules, so check these timestamps before comparing signals.

Price time means the latest available trade or regular-market close. Other times show when that section was checked or published.

PriceLive
Last traded •
Source: Market data provider
Fundamentalsevery 1 day
Provider checked •
Source: Market data provider
Analystevery 1 day
Provider checked •
Source: Market data provider
Newsevery 15 min
Latest item •
Source: Market data provider

Ownership read

ABT insider sentiment: Mixed, buy-heavy.

8 sales and 5 purchases appear in the recent Form 4 filings. Use the filters below to separate real buying and selling from option exercises, gifts, awards, and tax withholding.

Review insider tradesView institutions

Insider flow

ABT

Purchases20.44M
Sales511.26K

Directional bars ignore awards, gifts, conversions, and tax withholding rows.

Top holder

—

Institutional data pending

Insider stance

Mixed, buy-heavy

$60.44M sold / $2.11B bought

Latest filing

Apr 28, 2026

Most recent holder or insider filing date

Filings shown

84

0 holder / 84 insider

Holder rows
Pending
Market data source
Latest filing
Apr 28, 2026
Most recent holder or insider filing date
Increased / initiated
Pending
0 decreased
Insider rows
84
Market data source

Recent insider transactions

Abbott Laboratories (ABT) Form 4 filings

Action codes are translated so open-market buys and sales are separate from awards, gifts, conversions, and tax withholding.

Moreland Mary K

IProvider-supplied Form 4 action code. Review the original filing before making a trading judgment.
Shares
17.16K
% company
<0.01%
Price
$94.41
Value
$1,619,981

Filed Apr 28, 2026

STARKS DANIEL J

PurchaseOpen-market or direct purchase reported on Form 4.
Shares
6.75M
% company
0.39%
Price
$92.65
Value
$625,514,672

Filed Apr 27, 2026

Ahuja Nita

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
2.29K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Apr 24, 2026

Gonzalez Patricia Paola

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
9.21K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Apr 24, 2026

STARKS DANIEL J

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
7.11K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Apr 24, 2026

STARKS DANIEL J

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
6.74M
% company
0.39%
Price
No cash value
Value
No cash value

Filed Apr 24, 2026

McDew Darren W

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
12.68K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Apr 24, 2026

Babineaux-Fontenot Claire

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
7.60K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Apr 24, 2026

Kumbier Michelle

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
18.00K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Apr 24, 2026

Roman Michael F

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
10.76K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Apr 24, 2026

Blount Sally E.

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
36.34K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Apr 24, 2026

O'Grady Michael

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
5.93K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Apr 24, 2026

Showing 12 of 84 matching Form 4 rows. Percent of company uses current shares outstanding when available.Load more insiders

Frequently asked

Common questions.

Who are the largest ABT shareholders?

Abbott Laboratories (ABT) institutional holders are ranked by reported share count when ownership data publishes filing rows.

What is institutional ownership of ABT?

Abbott Laboratories (ABT) institutional ownership appears when filing-based market data returns holder rows. TECHi does not fill unavailable ownership fields with placeholder shareholders.

Where can I see Abbott Laboratories insider transactions?

Abbott Laboratories (ABT) has 84 Form 4 insider transactions on file, most recently on Apr 28, 2026, separated into purchases, sales, option exercises, awards, gifts, and tax withholding so administrative transactions are distinguished from open-market trades.

Are ABT insiders buying or selling?

Recent ABT insider activity reads Mixed, buy-heavy: 8 sales and 5 purchases. Awards, gifts, conversions, and tax withholding are listed separately because they do not carry the same signal as open-market trades.

Who is the most active ABT insider?

STARKS DANIEL J is the most active ABT insider by absolute share movement, with 26.97 million shares moving across the filing history. Review the action labels before treating that activity as buying or selling.